Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benralizumab Effectiveness in the LONG-term Real-life Setting in EGPA: The BELONG-EGPA Study

NCT07815886 is registered in ClinicalTrials.gov with European EGPA Study Group as lead sponsor.

NCT NCT07815886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benralizumab Effectiveness in the LONG-term Real-life Setting in EGPA: The BELONG-EGPA Study
Lead sponsor
European EGPA Study Group
Phase
Observational
Overall status
Recruiting
Start date
February 11, 2026
Completion date
February 11, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic granulomatosis with polyangiitis (egpa)